Clinical Laserthermia Systems
3.36
SEK
0 %
Less than 1K followers
CLS B
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
0%
-11.58%
-8.2%
-17.65%
-43.81%
-79.96%
-97.96%
-98.52%
-98.64%
Clinical Laserthermia Systems is a company active in medical technology. The company's vision is to develop and streamline the treatment of solid cancer tumors, where the company is a seller of sterile patient kits. The products are used in various cancer treatments such as malignant melanoma, as well as cancer in the lungs, liver, and pancreas. The company was founded in 2006 and is headquartered in Lund.
Read moreMarket cap
86.24M SEK
Turnover
65.79K SEK
Revenue
18.78M
EBIT %
-288.87 %
P/E
-
Dividend yield-%
-
Financial calendar
16.5
2025
Interim report Q1'25
27.6
2025
General meeting '25
15.8
2025
Interim report Q2'25
ShowingAll content types
CLS: Clinical Laserthermia Systems AB raises up to SEK 37m through a directed issue for accelerated commercialization and expansion
BioStock: CLS continues toward the goal of becoming cash flow positive by 2026
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools